Ramiah Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Ramiah Investment Group's ABBV Position: Q2 2026 in Review
Ramiah Investment Group reduced its AbbVie (ABBV) stake by 5.2% in Q2 2026, selling an estimated $22.2K and leaving 1,865 shares worth $469K. The position accounts for 0.36% of the portfolio, ranked #39.
Ramiah Investment Group first reported a position in ABBV in Q2 2020 and has held it in 6 quarters since. The position peaked at $544K in Q3 2025. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Ramiah Investment Group held 1,865 shares of AbbVie worth $469K as of Q2 2026.
- Ramiah Investment Group sold 103 AbbVie shares in Q2 2026, an estimated $22.2K.
- AbbVie made up 0.36% of Ramiah Investment Group's portfolio in Q2 2026, its #39 holding.
- Ramiah Investment Group first reported a position in AbbVie in Q2 2020 and has held it in 6 quarters since.
- Ramiah Investment Group's AbbVie position peaked at $544K in Q3 2025.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.